Comparison of the therapeutic effects of M1 and Bifrontal TDCS in the treatment of patients with shoulder girdle myofascial syndrome.

Not Applicable

Recruiting

Conditions: Condition 1: Myofascial pain syndrome. Condition 2: Myofascial pain syndrome.
Myalgia
Chronic pain syndrome
M79.1
G89.4

Registration Number: IRCT20081004001292N6

Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

Diagnosis of chronic myofascial pain in the shoulder girdle.
A history of at least 3 months of pain due to shoulder girdle myofascial pain syndrome.
Spontaneous pain in at least one of the trigger points in the trapezius, supraspinatus, rhomboid, and levator scapulae muscles.
Use of stable dose of painkillers, at least 3 months prior to the study.
Pain intensity of 5 or greater with VAS criteria over the past week.
Age between 18 and 50 years old.

Exclusion Criteria

Previous diagnosis of shoulder pathology other than MPS that can help with pain, including partial dislocation, instability, fracture, frozen shoulder, infection and inflammation.
Cervical radiculopathy based on clinical examinations.
Diagnosis of neurological diseases such as Alzheimer's or Parkinson's.
Severe psychological conditions or symptoms such as schizophrenia, major depression or mania.
Current pregnancy or lactation.
History of seizures.
Defects in the skull bone.
Existence of skin scar at the electrode installation site.
Tumors in the tissue of the areas below the electrode.
Current use of herbal remedies or other alternative therapies such as recent topical injections for pain.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain threshold. Timepoint: Before and immediately after the intervention. Method of measurement: Wagner digital Pain algometer.;Self-Perception of improvement. Timepoint: Before and immediately after the intervention. Method of measurement: Pain Self-Efficacy Questionnaire (PSEQ).

Secondary Outcome Measures